Effects of alkalization therapy on chemotherapy in metastatic or recurrent pancreatic cancer, retrospective study
Not Applicable
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000035659
- Lead Sponsor
- Japanese Society on Inflammation and Metabolism in Cancer
- Brief Summary
The mean urine pH was significantly higher after the alkalization therapy (6.85 +- 0.74 vs. 6.39 +- 0.92; p < 0.05). The median overall survival from the start of alkalization therapy of the patients with high urine pH (< 7.0) was significantly longer than those with low urine pH (<= 7.0)(16.1 vs. 4.7 months; p < 0.05).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who could not follow the alkalization therapy and/or visited our clinic less than 3 times.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method